Filing Details

Accession Number:
0000315066-12-003783
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-11 17:42:05
Reporting Period:
2012-07-09
Filing Date:
2012-07-11
Accepted Time:
2012-07-11 16:42:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1446847 Ironwood Pharmaceuticals Inc IRWD Pharmaceutical Preparations (2834) 043404176
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315066 Fmr Llc 82 Devonshire Street
Boston MA 02109
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2012-07-09 14,055 $13.77 2,345,791 No 4 S Indirect Footnote
Class A Common Stock Disposition 2012-07-10 4,900 $13.86 2,340,891 No 4 S Indirect Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Footnote
No 4 S Indirect Footnote
Footnotes
  1. Column 5 Amount of Securities Beneficially Owned Following Reported Transaction is held by Impresa Fund II LLC (1,030,189 Class A Common Stock), Impresa Fund III Limited Partnership (74,798 Class A Common Stock), Fidelity BioSciences Corp. (10,971 Class A Common Stock) and FIL Limited (1,224,933 Class A Common Stock). Column 5 does not include shares beneficially owned by Fidelity Management & Research Company as a result of acting as investment adviser to various investment companies as disclosed in Remark 1 below.